HOME >> MEDICINE >> NEWS
AMITIZA(TM) (lubiprostone) shown effective and well-tolerated in people older than age 65

AMITIZA(TM) (lubiprostone), the first selective chloride channel activator for the treatment of chronic idiopathic constipation, was effective and well-tolerated in treating the symptoms of chronic idiopathic constipation in the elderly adult population according to findings presented during a poster session today at Digestive Disease Week 2006.

"AMITIZA is unique among prescription treatments for chronic idiopathic constipation, given its novel mechanism of action, which has been shown to provide targeted and predictable relief to people living with this condition," said John Johanson, M.D., clinical associate professor, University of Illinois College of Medicine. "These results further support that AMITIZA may fill an important unmet need for many patients, especially those over age 65, for whom there are limited prescription treatment options currently available to treat chronic idiopathic constipation."

Predictable relief is defined as the ability of study participants to have three spontaneous bowel movements or more per week.

Constipation is one of the most common digestive complaints, affecting more than 30 million Americans, and is especially prevalent in adults over the age of 65. It is the cause of 2.5 million visits to physicians and 92,000 hospitalizations annually. AMITIZA is the only prescription medication for chronic idiopathic constipation that can be used in people age 65+ for longer than two weeks. Approximately one of four patients over 65 suffers from chronic constipation, a condition that increases with age-related bowel changes.

AMITIZA, approved by the U.S. Food and Drug Administration (FDA) in January 2006, is an oral treatment that works by increasing fluid secretion in the small intestine by activating ClC-2 chloride channels, and thereby increasing the passage of the stool and improving symptoms associated with chronic idiopathic constipation. AMITIZA was developed by Sucampo Pharmaceuticals, Inc., an
'"/>

Contact: Jocelyn M. Gerst
847-383-3696
Ketchum
22-May-2006


Page: 1 2

Related medicine news :

1. New study demonstrates that AMITIZA (lubiprostone) may help improve symptoms
2. AMITIZA (lubiprostone) launches in the United States
3. Pro-vitamin E shown to be active against breast cancer cells
4. Ultra low-dose estrogen shown safe for post-menopausal women
5. ROZEREM (ramelteon) shown to be effective in a first-night-effect model of transient
6. Radiation therapy shown to increase survival in certain lung cancer patients
7. Drug shown to provide much needed alternative therapy for chronic shoulder pain
8. Nexium shown to reduce gastric ulcers in at-risk patients using long-term NSAIDS
9. State board-disciplined physicians more likely to have shown unprofessional behavior in med school
10. Technology for successful aging shown at White House conference
11. Stress echo tests shown to predict cardiac death, illness in higher-risk women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... LONDON (PRWEB) , ... December 05, 2018 , ... ... misdiagnosed and the causes of this condition are poorly understood. It manifests on ... not a life threatening condition, it can cause enormous social and psychological problems. ...
(Date:12/5/2018)... ... , ... Domenic Palmieri has been named chief operating officer ... for the executive oversight of operations for three core divisions within HM, including ... position,” Tom Doran, president, HM Insurance Group, said. “And while we had significant ...
(Date:12/5/2018)... ... December 05, 2018 , ... To change ... Unitek’s transformative conference at the DoubleTree Hilton Hotel in Newark, California. Led by ... and Founder/Director of Watson Caring Science Institute, participants and esteemed guests discussed the ...
(Date:11/29/2018)... ... 2018 , ... The National Association of Chronic Disease Directors ... Preventing Chronic Disease is Essential - Prevention Works ,” to support federal funding ... , The paper outlines some of the strongest public health, economic, and ...
(Date:11/29/2018)... ... November 29, 2018 , ... The Lake Trust Foundation received ... and a razor for distribution to eight Michigan homeless shelters. Lake Trust Credit Union ... or more of the organizations to be selected by the internal Lake Trust Credit ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... ... December 05, 2018 , ... Medical Device Cybersecurity Risks ... Webinar**, Tuesday, Dec. 18, 2018, 1:30 p.m. - 3:00 p.m. ET, ... , Cybersecurity is becoming an everyday risk. , FDAnews has reached out ...
(Date:12/5/2018)... Va. (PRWEB) , ... December 05, 2018 , ... ... today that Mary Crivellone, PhD, the former Director of Global Laboratory Integration at ... Consultant. Dr. Crivellone is a Laboratory Operations executive with extensive experience in domestic ...
(Date:11/29/2018)... AUSTIN, Texas (PRWEB) , ... November 29, 2018 ... ... cycle management (RCM) and electronic health records (EHR) technology for acute care, post-acute ... to Vice President of Customer Support and Service. Hynds will lead Cantata Health’s ...
Breaking Medicine Technology:
Cached News: